Kashyap Sangeeta R, Desouza Cyrus, Aroda Vanita R, Kim Sun H, Neff Lisa M, Wu Shannon S, Raskin Philip, Pratley Richard
Cleveland Clinic, Cleveland, OH, USA.
Omaha VA Medical Center, University of Nebraska Medical Center, Omaha, NE, USA.
Am J Prev Cardiol. 2023 Jul 27;15:100525. doi: 10.1016/j.ajpc.2023.100525. eCollection 2023 Sep.
Prediabetes represents a spectrum of metabolic abnormalities, including insulin resistance and secretory impairment, that carries increased cardiovascular disease (CVD) risk. It is unclear whether specific glycemic and metabolic sub-classifications are associated with CVD risk. This cross-sectional analysis of 3946 participants from the Vitamin D and Type 2 Diabetes (D2d) study cohort aimed to determine the associations between various baseline CVD risk factors, glycemic sub-classifications of prediabetes (FPG, 2hPG, and HbA1c), and measures of insulin sensitivity and secretion from an OGTT.
The metabolic syndrome and atherosclerotic cardiovascular disease (ASCVD) risk scores were determined for tertiles of insulin sensitivity (HOMA2S) and insulinogenic index (IGI). Unadjusted analyses showed elevated CVD risk factors in the lowest tertile for both IGI and HOMA2S.
After adjustment for age, gender, race, obesity, and smoking status, the association remained between HOMA2S and ASCVD score ( = -0.11, < 0.001) but not for IGI. Those who met at least 2 diagnosic criteria for prediabetes had the largest proportion (> 40%) of participants with high ASCVD risk score >20. A higher percentage of individuals that met all 3 criteria for prediabetes had metabolic syndrome and ASCVD risk score >20 (87.2% and 15.3%, respectively) than those who only met 1 prediabetes criterion (51.6% and 7.1%, respectively).
In conclusion, multiple metabolic (HOMA2S, IGI) and glycemic criteria of prediabetes (FPG, 2hPG, & HbA1c) are needed to fully recognize the elevated CVD risk profile that can manifest in prediabetes.
糖尿病前期代表了一系列代谢异常,包括胰岛素抵抗和分泌功能受损,其心血管疾病(CVD)风险增加。目前尚不清楚特定的血糖和代谢亚分类是否与CVD风险相关。这项对维生素D与2型糖尿病(D2d)研究队列中3946名参与者的横断面分析旨在确定各种基线CVD风险因素、糖尿病前期的血糖亚分类(空腹血糖、餐后2小时血糖和糖化血红蛋白)以及口服葡萄糖耐量试验中胰岛素敏感性和分泌指标之间的关联。
针对胰岛素敏感性(HOMA2S)和胰岛素生成指数(IGI)的三分位数确定代谢综合征和动脉粥样硬化性心血管疾病(ASCVD)风险评分。未经调整的分析显示,IGI和HOMA2S最低三分位数的CVD风险因素升高。
在调整年龄、性别、种族、肥胖和吸烟状况后,HOMA2S与ASCVD评分之间仍存在关联(β = -0.11,P < 0.001),但IGI与ASCVD评分之间无关联。符合至少2项糖尿病前期诊断标准的人群中,ASCVD风险评分>20的参与者比例最高(>40%)。符合所有3项糖尿病前期标准的个体中,患有代谢综合征和ASCVD风险评分>20的比例(分别为87.2%和15.3%)高于仅符合1项糖尿病前期标准的个体(分别为51.6%和7.1%)。
总之,需要综合考虑糖尿病前期的多种代谢指标(HOMA2S、IGI)和血糖指标(空腹血糖、餐后2小时血糖和糖化血红蛋白),才能全面认识糖尿病前期可能出现的CVD风险升高情况。